APA (7th ed.) Citation

Cai, Q., Xu, B., Zhang, P., Ma, J., Liang, J., Le, L., . . . Zhang, X. (2025). The efficacy and safety of gemcitabine and docetaxel in pseudomyogenic hemangioendothelioma: A multi-center experience. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14376-6

Chicago Style (17th ed.) Citation

Cai, Qiyan, et al. "The Efficacy and Safety of Gemcitabine and Docetaxel in Pseudomyogenic Hemangioendothelioma: A Multi-center Experience." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14376-6.

MLA (9th ed.) Citation

Cai, Qiyan, et al. "The Efficacy and Safety of Gemcitabine and Docetaxel in Pseudomyogenic Hemangioendothelioma: A Multi-center Experience." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14376-6.